Title for MeetingAbstracts
Alphabetical listing of titles
Enhanced immunogenicity of HTLV-I envelope peptides presented with promiscuous T-cell peptides.
Enhanced Immunogenicity of Nasally Administered HIV Peptides Using Mucoadhesive Polymers.
Enhanced Immunogenicity to HIV-1 Envelope Using DNA Vaccines.
Enhanced immunoglobulin production by lymphocytes from HIV+ patients is due in part to prostaglandins and other monocyte products.
Enhanced interferon-gamma production in CD8+ but not in CD4+ T cells from HIV+ patients.
Enhanced knowledge of HIV infection does not prevent high-risk behaviour in experienced hospital staff.
Enhanced Laboratory Detection of Plasmid-Mediated AmpC Beta-lactamases in Escherichia coli and Klebsiella spp.
Enhanced lipid peroxidation by cells in semen from HIV-infected men.
Enhanced Maturation of Clinical Grade Human Dendritic Cells Using Different Plastic Surfaces and Cryopreservation Techniques.
Enhanced Medicaid rates for the treatment of HIV.
Enhanced neurotoxicity by the macrophage-astroglia interaction is unique to CSF-derived HIV-1 isolates.
Enhanced neutralization activity of sera derived from rabbits immunized with an oligomeric form of HIV-1 envelope protein.
Enhanced Neutralizing Antibody Responses Induced in Rhesus Macaques by o-gp140DV2 SF162 in a Prime-Boost Regimen.
Enhanced Nursing Home Rehabilitation Therapy for Post-acute Stroke Patients.
Enhanced of phagocytosis and germicidal activity in originating neutrophils and monocytes from bone marrow cells cultures of AIDS patients.
Enhanced pathogenicity of SHIV HXBc2 following whole blood passage in Macaca nemestrina.
Enhanced pathogenicity of SHIV HXBc2 following whole blood passage in Macaca nemestrina.
Enhanced penetration of indinavir (IDV) in cerebrospinal fluid and semen after addition of low-dose ritonavir (RTV).
Enhanced performance of a HIV-1 genotyping assay due to RNA denaturation performed prior to reverse transcription.
Enhanced Post Marketing Surveillance Approach to Drug Adverse Event Reporting: The Case of Lipid Lowering Drugs.
Enhanced Potency RNA Optimized HIV-1 Plasmid Vaccines Encoding Engineered B7 Costimulatory Molecules or IL-15.
Enhanced prediction of AIDS in HIV sero-positive asymptomatic men: relative value of 8 cellular and serologic markers singly and in combination.
Enhanced presentation of HIV gp120 to specific human T helper cells.
Enhanced production of monocyte-derived suppressive factors by HIV exposed, uninfected (EU) individuals.
Enhanced Production of Mutacin I and III from Streptococcus mutans.
Enhanced Production of Primary Isolates of HIV-1 in CD4-Enriched Cell Substrate.
Enhanced production of tumor necrosis factor in symptomatic HIV infections.
Enhanced Protective Efficacy of Vaccinia Virus/Protein Vaccine Regimen Containing Polyvalent Envelope Against a Pathogenic SHIV in Rhesus Macaques.
Enhanced Regional Surveillance of Methicillin-Resistant Staphylococcus aureus.
Enhanced resistance to in vitro phagocytosis, of logarithmic growing Cryptococcus neoformans by the early production of a phagocytosis inhibitory protein (IP).